Raj Kumar Samal has assumed the role of Vice President – Sales & Marketing for the Unify Division at Jagsonpal Pharmaceuticals Ltd., bringing with him over two decades of seasoned expertise in the Indian pharmaceutical industry. In his current position, Raj Kumar is leading the growth, market expansion, and strategic planning for the division from the company’s Mumbai headquarters.
Before joining Jagsonpal in October 2023, Raj Kumar served as SBU Head for the Derma Division at Wallace Pharmaceuticals, where he spent four successful years. During his tenure, he played a pivotal role in repositioning the dermatology portfolio and scaling up revenue streams across multiple zones. His leadership was marked by strong team-building, innovative marketing strategies, and a results-driven culture.
Raj’s earlier experience includes a long stint at Alembic Pharmaceuticals, where he held the dual responsibility of AGM – Sales & Marketing for over five years. He also worked with leading pharma giants such as Sandoz (Novartis), Allergan India, and Ipca Laboratories, managing diverse portfolios and regional business units, particularly across the western and northern Indian markets.
An alumnus of prestigious institutions including the Indian School of Business, Annamalai University, and AIMA, Raj Kumar has constantly blended academic rigour with on-ground execution. His background in electronics, paired with diplomas in marketing and international business, has equipped him with a unique strategic lens for managing complex pharma operations.
With his deep domain knowledge, Raj Kumar’s appointment is expected to strengthen the Unify Division’s footprint in the Indian market. As he takes charge, the industry anticipates fresh momentum in Jagsonpal’s brand positioning and customer engagement across therapeutic segments.